الوصف
Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups.
Figure 2
ChartSource Paper
Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.Cite This Figure
![Figure 2: Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups.]() > Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." *Nutrients*, 2020. PMID: [32019158](https://pubmed.ncbi.nlm.nih.gov/32019158/)
<figure> <img src="" alt="Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups." /> <figcaption>Figure 2. Abdominal pain severity scores measured at baseline and across study visits for participants receiving L. acidophilus DDS-1, B. lactis UABla-12, or placebo, showing progressive improvement in the probiotic groups.<br> Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32019158/">32019158</a></figcaption> </figure>